Enterprise Value to EBITDA Multiple ratio Analysis of TherapeuticsMD Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY EV to EBITDA
Period Ending - Dec-23

0.260


Excellent EV to EBITDA
Period Ending - Dec-22
-0.846

Very Poor EV to EBITDA
Growth
130.76 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23

-4.13


Very Poor EV to EBITDA
EV to EBITDA Analysis of TherapeuticsMD Inc
Enterprise Value to EBITDA 0.260 of TherapeuticsMD Inc indicate that a company is more attractive or undervalued in the market.
EV to EBITDA Ratio of TXMD rose handsomely by 130.76 % this year.
EV to EBITDA Ratio of TXMD trending up for at least three Years.
EV to EBITDA Ratio with value of -1.06 was lowest in Year Dec-20 in last Five Years.
Latest EV to EBITDA Ratio with value of 0.260 is Greater than Average EV to EBITDA of -0.556 in last five years.
Other EV to EBITDA Related Info of TXMD that may interest you.
TherapeuticsMD Inc Overview
CodePricePrevious PricePrice ChangeSector
TXMD1.992.03 1.97 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple Formula
EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio
Tsr Value Index
Very Low Value Stock
FY - Historical Enterprise Value to EBITDA Multiple of TherapeuticsMD Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
EV to EBITDA0.260-0.846-0.911-1.06-0.2260.6901.66
Change130.76 %7.17 %13.92 %-369.15 %-132.70 %-58.32 %13.06 %
You are view first 7 Records. Log in to view all 33 in Premium view
FY Chart of Enterprise Value to EBITDA Multiple of TherapeuticsMD Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)